Vext Science has reopened its Jackson, Ohio cannabis dispensary following regulatory approval. The company also restructured $6 million in promissory notes tied to its Ohio acquisitions, reducing the immediate payment from $5.6 million to $2.4 million due in January 2027, with the remaining $3.2 million converted into fully amortizing notes payable through January 2029. This move improves Vext's liquidity and eliminates large year-end debt obligations, supporting ongoing operations and financial stability.
Vext Science's recent financial restructuring and dispensary reopening provide context for health-sector market activity. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 18, 2026 02:32 WIB: out of 91 priced US health-sector stocks tradable on Pluang, 65 rose and 26 fell. Notable movers include Illumina, Inc. (ILMN) with a price of USD 243.73 and a 1-day change of +6.46%, DENTSPLY SIRONA Inc (XRAY) at USD 9.51 down 6.26%, and Davita Inc (DVA) at USD 183.21 down 5.49%.
Jefferies maintained a Hold rating on Kinder Morgan, lowering its price target from $35 to $33, which remains above the current stock price of $31.31. The company benefits from stable cash flows, with 96% secured by fee-based or hedged contracts, inc...
Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings ro...
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
The Liquid Network hacker reportedly retains 598.5 BTC after a major exploit, even as about 3,400 BTC was recovered following a security patch. The L-BTC-to-Bitcoin conversion channel has been suspended for 11 days, blocking users from redeeming Liqu...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
